Other
Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss
CVS Health Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss decreased by 0.0% to $28.59B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.5%, from $26.35B to $28.59B. Over 4 years (FY 2021 to FY 2025), Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss shows an upward trend with a 6.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2021
Last reportedQ1 2026May 6, 2026
Metric ID:
other_debt_securities_available_for_sale_amortized_cost__4a59caHistorical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.17B | $22.8B | $22.2B | $22.24B | $22.06B | $22.11B | $22.27B | $22.1B | $22.28B | $23.31B | $24.55B | $26.43B | $26.56B | $26.35B | $26.66B | $27.71B | $28.6B | $28.59B |
| QoQ Change | — | +2.8% | -2.6% | +0.2% | -0.8% | +0.2% | +0.7% | -0.7% | +0.8% | +4.6% | +5.3% | +7.7% | +0.5% | -0.8% | +1.2% | +3.9% | +3.2% | -0.0% |
| YoY Change | — | — | — | — | -0.5% | -3.0% | +0.3% | -0.6% | +1.0% | +5.4% | +10.2% | +19.6% | +19.2% | +13.0% | +8.6% | +4.8% | +7.7% | +8.5% |
Range$22.06B – $28.6B
CAGR+6.2%
Avg YoY Growth+6.7%
Median YoY Growth+6.5%
Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss at Other Companies
Frequently Asked Questions
- What is CVS Health's debt securities, available-for-sale, amortized cost, after allowance for credit loss?
- CVS Health (CVS) reported debt securities, available-for-sale, amortized cost, after allowance for credit loss of $28.59B in Q1 2026.
- How has CVS Health's debt securities, available-for-sale, amortized cost, after allowance for credit loss changed year-over-year?
- CVS Health's debt securities, available-for-sale, amortized cost, after allowance for credit loss increased by 8.5% year-over-year, from $26.35B to $28.59B.
- What is the long-term trend for CVS Health's debt securities, available-for-sale, amortized cost, after allowance for credit loss?
- Over 4 years (2021 to 2025), CVS Health's debt securities, available-for-sale, amortized cost, after allowance for credit loss has grown at a 6.6% compound annual growth rate (CAGR), from $22.17B to $28.6B.